Varaico: Literature-Extracted Genetic Variants

Gene:SLC6A4
Variant:p.Y95F
Back to variants list

SLC6A4

NM_001045.6:p.Y95F

Associated Papers

Structural basis of vilazodone dual binding mode to the serotonin transporter.

Kalenderoglou IE et al.

Nature Communications, 2025

Structural basis of vilazodone dual binding mode to the serotonin transporter.

Kalenderoglou IE et al.

Research Square, 2025

The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter.

Plenge P et al.

Nature Communications, 2021

Binding of mazindol and analogs to the human serotonin and dopamine transporters.

Severinsen K et al.

Molecular Pharmacology, 2014

Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity.

Lynagh T et al.

Naunyn-schmiedeberg's Archives of Pharmacology, 2014

The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter.

Sarker S et al.

Molecular Pharmacology, 2010

Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine.

Field JR et al.

The Journal of Biological Chemistry, 2010

Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.

Andersen J et al.

The Journal of Biological Chemistry, 2010

Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.

Plenge P et al.

European Journal of Pharmacology, 2007

Homology modeling of the serotonin transporter: insights into the primary escitalopram-binding site.

Jørgensen AM et al.

Chemmedchem, 2007

Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.

Henry LK et al.

The Journal of Biological Chemistry, 2006

High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.

Barker EL et al.

The Journal of Biological Chemistry, 1998

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."